> The FDA has determined that more study of blood clotting risks is needed before it can take action on Johnson & Johnson's birth control patch. Report
> The FDA has approved Barrier Therapeutics' Vusion for the treatment of diaper dermatitis complicated by candidiasis. Report
> DURECT announced that its ready to launch a Phase III trial of the pain therapy Remoxy following a special protocol assessment with the FDA. Release
> Medigene has earned a milestone payment from Astellas following the launch of Eligard for prostate cancer in France. Report
> The antibiotic Tequin from Bristol-Myers Squibb will carry stronger safety warnings. Report
And Finally... A group of states is considering laws requiring drug makers to disclose all the gifts they make to physicians, hospitals and pharmacists. Article